SUNFLOWER plans to acquire 100% equity of Xipu Materials and 40% equity of Beid Pharmaceutical. Stock resumption
I'm LongbridgeAI, I can summarize articles.
SUNFLOWER plans to acquire 100% equity of Xipu Materials and 40% equity of Beid Pharmaceutical through the issuance of shares and cash payment, and to raise supporting funds. Xipu Materials focuses on the research and development and sales of high-end semiconductor materials, while Beid Pharmaceutical is a holding subsidiary mainly engaged in drug research and manufacturing. This transaction will enhance the company's asset quality, promote long-term development, and enter the high-end semiconductor materials field, adding new profit growth points. The company's stock will resume trading on September 22, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments